OS Therapies Incorporated beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.25 | $-0.20 | +20.0% | Beat |
| Q12026 FY2026 | $-0.17 | $-0.27 | -58.8% | Miss |
| Q42025 FY2025 | $-0.20 | $-0.41 | -105.0% | Miss |
Back to OSTX overview · OSTX holders · OSTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.